Skip to content Skip to navigation

Stanford depression treatment nearly 80% effective

Researchers demonstrate transcranial magnetic stimulation technology

Stanford researcher David Carreon demonstrates the equipment for Hope TMS, a clinical adaptation of the SNT technology currently being used at Stanford, on a patient and staff member. (Photo: AYA AZIZ/The Stanford Daily)

Dec 2 2021

By Brandon Kim

Stanford neuromodulation therapy (SNT), an experimental, accelerated version of magnetic pulse brain stimulation developed at Stanford, may provide a “revolutionary” treatment for severe depression, according to researchers at Stanford’s School of Medicine.

The researchers’ optimism comes on the heels of an Oct. 29 study in which the treatment was found to have induced remission in nearly 80% of participants. The study tested the efficacy of SNT on patients with long-term, moderate to severe depression who were also “treatment resistant,” meaning that they had unsuccessfully tried several other conventional forms of treatment. For many of these patients, SNT was the first treatment that successfully alleviated their depression in a significant, lasting way, researchers said.

“My brain has been rebooted,” said one patient treated with SNT who asked to remain anonymous due to concerns regarding the stigmatization of mental health treatment. “It’s like this cloud of depression has been lifted from me.”

Read more at the Stanford Daily